Compounds > 2-amino-5-phosphonovalerate
Page last updated: 2024-10-21

2-amino-5-phosphonovalerate and Encephalopathy, Traumatic

2-amino-5-phosphonovalerate has been researched along with Encephalopathy, Traumatic in 1 studies

2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vascak, M1
Jin, X1
Jacobs, KM1
Povlishock, JT1

Other Studies

1 other study available for 2-amino-5-phosphonovalerate and Encephalopathy, Traumatic

ArticleYear
Mild Traumatic Brain Injury Induces Structural and Functional Disconnection of Local Neocortical Inhibitory Networks via Parvalbumin Interneuron Diffuse Axonal Injury.
    Cerebral cortex (New York, N.Y. : 1991), 2018, 05-01, Volume: 28, Issue:5

    Topics: Action Potentials; Animals; Brain Injuries, Traumatic; Diffuse Axonal Injury; Disease Models, Animal

2018